Search results
Showing 16 to 30 of 163 results for asthma
Chronic obstructive pulmonary disease in over 16s: diagnosis and management (NG115)
This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (which includes emphysema and chronic bronchitis) in people aged 16 and older. It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, improve quality of life and keep them healthy for longer.
NICE is unable to make a recommendation on SQ HDM SLIT (Acarizax) for treating allergic rhinitis and allergic asthma in adults caused by house dust mites. This is because ALK-Abello did not provide an evidence submission. We will review this decision if the company decides to make a submission.
Show all sections
Sections for TA834
In development [GID-TA11355] Expected publication date: 09 July 2024
guidance and gold-standard policies on children and young people's (CYP) asthma are available, but we identified an opportunity for a...
Evidence-based recommendations on the use of inhaler systems (devices) for children under 5 years with chronic stable asthma.
NICE has developed a medtech innovation briefing (MIB) on Smartinhaler for asthma .
This guideline covers assessing and managing food allergy in children and young people under 19. It aims to improve symptoms such as faltering growth and eczema by offering advice on how to identify food allergy and when to refer to secondary or specialist care.
Impact of a pharmacist-led Asthma and COPD respiratory clinic in General Practice
joint initiative between City & Hackney CCG and Barts Health NHS Trust, asthma and COPD reviews were undertaken by a respiratory...
NICE has developed a medtech innovation briefing (MIB) on Smart Peak Flow for monitoring asthma .
2019 The NICE guideline on asthma (NG80) recommends that spirometry, bronchodilator reversibility, and fraction
NICE has developed a medtech innovation briefing (MIB) on Thora 3Di for assessing asthma in children .
Modern Innovative SolutionS Improving Outcomes iN Asthma Breathlessness and COPD (MISSION ABC)
gold-standard, vertically integrated, streamlined care to patients with asthma, COPD and undifferentiated breathlessness. MISSION ABC...
The Airsonett temperature-controlled laminar airflow device for persistent allergic asthma (MIB8)
NICE has developed a Medtech Innovation Briefing (MIB) on the Airsonett temperature-controlled laminar airflow device for persistent allergic asthma
Alair bronchial thermoplasty system for adults with severe difficult to control asthma (MIB71)
NICE has developed a medtech innovation briefing (MIB) on the Alair bronchial thermoplasty system for adults with severe, difficult to control asthma
Evidence-based recommendations on bronchial thermoplasty for severe asthma in adults. This involves applying heat to the inside walls of the airways.
View recommendations for IPG635Show all sections